Skip to content

Efficacy of electro-acupuncture for painful diabetic peripheral neuropathy: a randomised controlled trial.

Efficacy of electro-acupuncture for painful diabetic peripheral neuropathy: a randomised controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001762
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painful Diabetic Peripheral Neuropathy

Interventions

Electroacupuncture group:Electroacupuncture
Micro-electric acupuncture group:Blunt-tipped needles (0.30×25 mm) will be inserted through the adhesive foam pads at non-acupoint points but will not penetrate the skin.

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed with type 1 or type 2 diabetes mellitus; (2) The patient was diagnosed with painful diabetic peripheral neuropathy; (3) Aged 18-75 years; (4) The numeric rating scale for pain intensity of diabetic peripheral neuropathy =4 points; (5) Have not received drug treatment for painful diabetic peripheral neuropathy in the past 1 month; (6) Have not received acupuncture treatment in the past 3 months and have not participated in other ongoing clinical studies; (7) Sign informed consent to participate in the study voluntarily.

Exclusion criteria

Exclusion criteria: (1) Glycosylated hemoglobin > 9%; (2) Implantation of a pacemaker; (3) Pregnancy lactation or planned pregnancy; (4) Patients with malignant tumors or chemotherapy severe cardiovascular and cerebrovascular diseases infectious diseases vitamin B12 deficiency cervical and lumbar spine diseases hereditary neuropathy liver and kidney insufficiency; Alcoholism; (5) Have a history of cerebral hemorrhage inherited hemorrhagic disease (such as hemophilia) or are using anticoagulant drugs such as warfarin; (6) Foot ulcer or gangrene; (7) Patients with cognitive dysfunction aphasia or mental disorders cannot cooperate with this study; (8) Patients with peripheral neuropathy pain caused by other reasons; (9) Others are not appropriate for this research.

Design outcomes

Primary

MeasureTime frame
Pain relief rate;

Secondary

MeasureTime frame
Response rate for Numeric rating scale;Total symptom score;Beck Anxiety Inventory score;Pittsburgh Sleep Quality Index (PSQI) score;Blinding assessment;Beck Depression Inventory-II score;Nerve conduction velocity;Treatment expectancy;12-item short-form health survey;

Countries

China

Contacts

Public ContactYan shiyan

Beijing University of Chinese Medicine

yanshiyan0927@sina.com+86 135 2143 6209

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026